-
市場
-
產品
-
資訊
-
Moo社區
-
課堂
-
查看更多
-
功能介紹
-
費用費用透明，無最低余額限制
投資選擇、功能介紹、費用相關信息由Moomoo Financial Inc.提供
- English
- 中文繁體
- 中文简体
- 深色
- 淺色
ZIVO Bioscience (NASDAQ:ZIVOW) Shares Down 12.5%
ZIVO Bioscience (NASDAQ:ZIVOW) Shares Down 12.5%
Shares of ZIVO Bioscience, Inc. (NASDAQ:ZIVOW – Get Rating) fell 12.5% during trading on Friday . The stock traded as low as $0.60 and last traded at $0.63. 2,500 shares changed hands during mid-day trading, a decline of 42% from the average session volume of 4,339 shares. The stock had previously closed at $0.72.
ZIVO Bioscience Price Performance
The company has a 50 day moving average of $0.75 and a 200 day moving average of $0.74.
Get ZIVO Bioscience alerts:Institutional Investors Weigh In On ZIVO Bioscience
An institutional investor recently raised its position in ZIVO Bioscience stock. Warberg Asset Management LLC grew its holdings in ZIVO Bioscience, Inc. (NASDAQ:ZIVOW – Get Rating) by 442.0% in the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 84,654 shares of the company's stock after acquiring an additional 69,034 shares during the quarter. Warberg Asset Management LLC's holdings in ZIVO Bioscience were worth $51,000 at the end of the most recent reporting period.
ZIVO Bioscience Company Profile
(Get Rating)
ZIVO Bioscience, Inc is a Michigan-based biotech/agtech company dedicated to harnessing the immune health and nutritional benefits of bioactive compounds derived from its proprietary algal cultures. The development pipeline includes natural products for use as dietary supplements and functional food ingredients, as well as innovative, biologically derived and synthesized candidates designed to deliver medicinal and pharmaceutical benefits for humans and animals, with a specific focus on modulating the immune and inflammatory response.
Featured Stories
- Get a free copy of the StockNews.com research report on ZIVO Bioscience (ZIVOW)
- How to Invest in the Top Grocery Stocks for This Year
- Array Technologies Brings Solar Flare To 2023 Earnings Forecast
- Best Bank Stocks to Invest in Ahead of Rising Interest Rates
- How to Invest in Farmland: 7 Simple Ways
- ExxonMobil Gushes To New Highs
Receive News & Ratings for ZIVO Bioscience Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ZIVO Bioscience and related companies with MarketBeat.com's FREE daily email newsletter.
Shares of ZIVO Bioscience, Inc. (NASDAQ:ZIVOW – Get Rating) fell 12.5% during trading on Friday . The stock traded as low as $0.60 and last traded at $0.63. 2,500 shares changed hands during mid-day trading, a decline of 42% from the average session volume of 4,339 shares. The stock had previously closed at $0.72.
ZIVO Bioscience, Inc.（納斯達克股票代碼：ZIVOW — 獲取評級）的股價在週五的交易中下跌了12.5％。該股交易價格低至0.60美元，最後一次交易價格爲0.63美元。2,500股在午盤交易中易手，較4,339股的平均交易量下降了42％。該股此前收於0.72美元。
ZIVO Bioscience Price Performance
ZIVO 生物科學的價格表現
The company has a 50 day moving average of $0.75 and a 200 day moving average of $0.74.
該公司的50天移動平均線爲0.75美元，200天移動平均線爲0.74美元。
Institutional Investors Weigh In On ZIVO Bioscience
機構投資者關注ZIVO Bioscience
An institutional investor recently raised its position in ZIVO Bioscience stock. Warberg Asset Management LLC grew its holdings in ZIVO Bioscience, Inc. (NASDAQ:ZIVOW – Get Rating) by 442.0% in the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 84,654 shares of the company's stock after acquiring an additional 69,034 shares during the quarter. Warberg Asset Management LLC's holdings in ZIVO Bioscience were worth $51,000 at the end of the most recent reporting period.
一位機構投資者最近提高了其在ZIVO Bioscience股票中的頭寸。根據美國證券交易委員會（SEC）的最新披露，Warberg Asset Management LLC在第三季度將其在ZIVO Bioscience, Inc.（納斯達克股票代碼：ZIVOW — 獲取評級）的持股量增加了442.0％。該機構投資者在本季度又收購了69,034股股票後，擁有該公司84,654股股票。截至最近報告期末，Warberg Asset Management LLC在ZIVO Bioscience的持股價值51,000美元。
ZIVO Bioscience Company Profile
ZIVO 生物科學公司簡介
(Get Rating)
（獲取評分）
ZIVO Bioscience, Inc is a Michigan-based biotech/agtech company dedicated to harnessing the immune health and nutritional benefits of bioactive compounds derived from its proprietary algal cultures. The development pipeline includes natural products for use as dietary supplements and functional food ingredients, as well as innovative, biologically derived and synthesized candidates designed to deliver medicinal and pharmaceutical benefits for humans and animals, with a specific focus on modulating the immune and inflammatory response.
ZIVO Bioscience, Inc 是一家總部位於密歇根州的生物技術/農業科技公司，致力於利用其專有藻類培養物的生物活性化合物的免疫健康和營養益處。開發渠道包括用作膳食補充劑和功能性食品原料的天然產品，以及旨在爲人類和動物提供藥物和藥物功效的創新、生物衍生和合成的候選產品，特別側重於調節免疫和炎症反應。
Featured Stories
精選故事
- Get a free copy of the StockNews.com research report on ZIVO Bioscience (ZIVOW)
- How to Invest in the Top Grocery Stocks for This Year
- Array Technologies Brings Solar Flare To 2023 Earnings Forecast
- Best Bank Stocks to Invest in Ahead of Rising Interest Rates
- How to Invest in Farmland: 7 Simple Ways
- ExxonMobil Gushes To New Highs
- 免費獲取 StockNews.com 關於 ZIVO Bioscience (ZIVOW) 的研究報告的副本
- 如何投資今年最熱門的雜貨股
- Array Technologies將太陽耀斑帶入
- 在利率上升之前投資的最佳銀行股
- 如何投資農田：7 種簡單方法
- 埃克森美孚飆升至新高
Receive News & Ratings for ZIVO Bioscience Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ZIVO Bioscience and related companies with MarketBeat.com's FREE daily email newsletter.
接收 ZIVO 生物科學日報的新聞和收視率 -在下面輸入您的電子郵件地址，通過Marketbeat.com的免費每日電子郵件時事通訊接收ZIVO Bioscience及相關公司最新新聞和分析師評級的簡明每日摘要。
moomoo是Moomoo Technologies Inc.公司提供的金融資訊和交易應用程式。
在美國，moomoo上的投資產品和服務由Moomoo Financial Inc.提供，一家受美國證券交易委員會（SEC）監管的持牌主體。 Moomoo Financial Inc.是金融業監管局（FINRA）和證券投資者保護公司（SIPC）的成員。
在新加坡，moomoo上的投資產品和服務是通過Moomoo Financial Singapore Pte. Ltd.提供，該公司受新加坡金融管理局（MAS）監管(牌照號碼︰CMS101000) ，持有資本市場服務牌照 (CMS) ，持有財務顧問豁免（Exempt Financial Adviser）資質。本內容未經新加坡金融管理局的審查。
在澳大利亞，moomoo上的金融產品和服務是通過Futu Securities (Australia) Ltd提供，該公司是受澳大利亞證券和投資委員會(ASIC)監管的澳大利亞金融服務許可機構（AFSL No. 224663）。請閱讀並理解我們的《金融服務指南》、《條款與條件》、《隱私政策》和其他披露文件，這些文件可在我們的網站 https://www.moomoo.com/au中獲取。
在加拿大，透過moomoo應用程式提供的僅限訂單執行的券商服務由Moomoo Financial Canada Inc.提供，並受加拿大投資監管機構（CIRO）監管。
在馬來西亞，moomoo上的投資產品和服務是透過Moomoo Securities Malaysia Sdn. Bhd. 提供，該公司受馬來西亞證券監督委員會（SC）監管(牌照號碼︰eCMSL/A0397/2024) ，持有資本市場服務牌照 (CMSL) 。本內容未經馬來西亞證券監督委員會的審查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd.，Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc和Moomoo Securities Malaysia Sdn. Bhd., 是關聯公司。
風險及免責聲明
moomoo是Moomoo Technologies Inc.公司提供的金融資訊和交易應用程式。
在美國，moomoo上的投資產品和服務由Moomoo Financial Inc.提供，一家受美國證券交易委員會（SEC）監管的持牌主體。 Moomoo Financial Inc.是金融業監管局（FINRA）和證券投資者保護公司（SIPC）的成員。
在新加坡，moomoo上的投資產品和服務是通過Moomoo Financial Singapore Pte. Ltd.提供，該公司受新加坡金融管理局（MAS）監管(牌照號碼︰CMS101000) ，持有資本市場服務牌照 (CMS) ，持有財務顧問豁免（Exempt Financial Adviser）資質。本內容未經新加坡金融管理局的審查。
在澳大利亞，moomoo上的金融產品和服務是通過Futu Securities (Australia) Ltd提供，該公司是受澳大利亞證券和投資委員會(ASIC)監管的澳大利亞金融服務許可機構（AFSL No. 224663）。請閱讀並理解我們的《金融服務指南》、《條款與條件》、《隱私政策》和其他披露文件，這些文件可在我們的網站 https://www.moomoo.com/au中獲取。
在加拿大，透過moomoo應用程式提供的僅限訂單執行的券商服務由Moomoo Financial Canada Inc.提供，並受加拿大投資監管機構（CIRO）監管。
在馬來西亞，moomoo上的投資產品和服務是透過Moomoo Securities Malaysia Sdn. Bhd. 提供，該公司受馬來西亞證券監督委員會（SC）監管(牌照號碼︰eCMSL/A0397/2024) ，持有資本市場服務牌照 (CMSL) 。本內容未經馬來西亞證券監督委員會的審查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd.，Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc和Moomoo Securities Malaysia Sdn. Bhd., 是關聯公司。
- 分享到weixin
- 分享到qq
- 分享到facebook
- 分享到twitter
- 分享到微博
- 粘贴板
使用瀏覽器的分享功能，分享給你的好友吧